Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Mano

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
The Journal of Urology|February 14, 2015
Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell CarcinomaMichael Chevinsky, Mariam Imnadze, Alexander Sankin, et al.
Nutrients|August 26, 2023
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, et al.
European Urology Focus|March 20, 2024
Sterile Water Versus Glycine in Transurethral Resection of Bladder Tumors-Immunogenic and Clinical ImplicationsHaim Herzberg, Roi Babaoof, Ron Marom, et al.
Nutrients|December 28, 2021
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, et al.
BJU International|April 27, 2022
Association between early change in neutrophil-to-lymphocyte ratio after radical cystectomy and treatment outcomesHaim Herzberg, Karin Lifshitz, Shay Golan, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
An evaluation of the role of tumor load in cytoreductive nephrectomyAndrew W Silagy, Cihan Duzgol, Julian Marcon, et al.
Bladder Cancer (Amsterdam, Netherlands)|October 24, 2022
Urethral Melanoma - Clinical, Pathological and Molecular CharacteristicsRoy Mano, Benedikt Hoeh, Renzo G DiNatale, et al.
BJU International|July 1, 2021
The association between modifiable perioperative parameters and renal function after nephrectomyRoy Mano, Amy L Tin, Andrew W Silagy, et al.
Clinical Genitourinary Cancer|June 26, 2022
Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell CarcinomaAndrew W Silagy, Amy L Tin, Phillip Rappold, et al.
Urologic Oncology|September 16, 2019
Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinomaAndrew W Silagy, Jessica Flynn, Roy Mano, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
The Journal of Urology|February 14, 2015
Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell CarcinomaMichael Chevinsky, Mariam Imnadze, Alexander Sankin, et al.
Nutrients|August 26, 2023
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, et al.
European Urology Focus|March 20, 2024
Sterile Water Versus Glycine in Transurethral Resection of Bladder Tumors-Immunogenic and Clinical ImplicationsHaim Herzberg, Roi Babaoof, Ron Marom, et al.
Nutrients|December 28, 2021
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, et al.
BJU International|April 27, 2022
Association between early change in neutrophil-to-lymphocyte ratio after radical cystectomy and treatment outcomesHaim Herzberg, Karin Lifshitz, Shay Golan, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
An evaluation of the role of tumor load in cytoreductive nephrectomyAndrew W Silagy, Cihan Duzgol, Julian Marcon, et al.
Bladder Cancer (Amsterdam, Netherlands)|October 24, 2022
Urethral Melanoma - Clinical, Pathological and Molecular CharacteristicsRoy Mano, Benedikt Hoeh, Renzo G DiNatale, et al.
BJU International|July 1, 2021
The association between modifiable perioperative parameters and renal function after nephrectomyRoy Mano, Amy L Tin, Andrew W Silagy, et al.
Clinical Genitourinary Cancer|June 26, 2022
Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell CarcinomaAndrew W Silagy, Amy L Tin, Phillip Rappold, et al.
Urologic Oncology|September 16, 2019
Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinomaAndrew W Silagy, Jessica Flynn, Roy Mano, et al.
Pageof 12